← Procter & Gamble
Ratio Review
Calculated financial tables and DSCR projections
Validation Warnings
1 warnings
3 info
Warning
Balance sheet incomplete for FY2023: missing components to verify Assets = L + E.
Info
loc_availabilityUndrawn credit facility not provided for FY2023. Liquidity analysis may be incomplete.
Info
loc_availabilityUndrawn credit facility not provided for FY2024. Liquidity analysis may be incomplete.
Info
loc_availabilityUndrawn credit facility not provided for FY2025. Liquidity analysis may be incomplete.
Income Statement, Activity & Profitability
| Line Item | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Revenues | $82006.0M | $84039.0M | $84284.0M |
| Revenues y/o/y growth | N/A | 2.5% | 0.3% |
| Gross Profit | $39246.0M | $43191.0M | $43120.0M |
| Gross Margin % | 47.9% | 51.4% | 51.2% |
| EBITDA* | $16403.0M | $16479.0M | $18921.0M |
| EBITDA Margin % | 20.0% | 19.6% | 22.4% |
| EBITDA (Op. Lease Adj.)** | $16403.0M | $16479.0M | $18921.0M |
| Operating Profit | $18134.0M | $18545.0M | $20451.0M |
| Operating Margin % | 22.1% | 22.1% | 24.3% |
| Net Income | $14519.0M | $14758.0M | $16349.0M |
| Net Margin % | 17.7% | 17.6% | 19.4% |